Antibodies that inhibit erythrocyte invasion by Plasmodium falciparum and their role in protective immunity

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/356237

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Malaria continues to be a leading cause of death and disease globally, resulting in up to 3 million deaths annually, mainly among children. After repeated episodes of malaria, children that survive develop immune responses that protect them against further episodes. Currently, it is not well understood how these protective immune responses work. Malaria parasites infect red blood cells and multiply inside them, leading to the symptoms and serious complications of malaria. Antibodies that block the entry of parasites into red blood cells have been found in adults who are immune to malaria, and can be stimulated by certain vaccines, but little is known about this immune response and whether it is effective in protecting against malaria. Many investigators have focussed on the detection of antibodies, but we will focus on the function of antibodies in blocking parasite entry into red blood cells, thereby blocking parasite growth. We will examine how these antibodies develop among children at risk of malaria living in a region of Kenya where malaria is a major cause of death, and whether these antibodies protect children against malarial illness. Malaria parasites produce a variety of different proteins that enable them to stick and then enter red blood cells. We will identify the main proteins that antibodies target to block malaria growth. We will also determine whether variations in the proteins produced by malaria are used to avoid immune responses. Results from these studies will advance our understanding of how the immune system protects against malaria. With this knowledge, vaccines can be designed that will target essential malaria proteins, and reduce or prevent malaria infection and illness.

Funded Activity Details

Start Date: 01-01-2005

End Date: 01-01-2007

Funding Scheme: NHMRC Project Grants

Funding Amount: $389,250.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical Parasitology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Plasmodium falciparum malaria | cell adhesion | childhood malaria | children | infectious diseases | maternal and child health

Related Links